CARLSBAD, Calif., Oct. 24 Isis Pharmaceuticals,Inc. (Nasdaq: ISIS) announced today that its majority-owned subsidiary, IbisBiosciences, Inc. (Ibis), and collaborators are presenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results